SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · CEO Claire Mazumdar and President Ryan Cohlhepp of Bicara Therapeutics…

Bicara Therapeutics Inc. · CLUSTER filed Mar 15, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 15, 2026 at 20:00 ET

CEO Claire Mazumdar and President Ryan Cohlhepp of Bicara Therapeutics (BCAX) exercised stock options and sold shares in a coordinated cluster over four days, generating $302,422 in open-market sales. The transactions represent modest insider selling following derivative exercises, with total proceeds under 0.1% of the company's $1.0B market cap.

  • CEO Claire Mazumdar sold 15,000 shares for $282,366 across three days (March 18–20), following full option exercises.
  • President Ryan Cohlhepp sold 8,000 shares for $157,257 on March 16 after exercising options.
  • All sales were open-market transactions (code S) preceded by derivative exercises (code M).
  • Total cash proceeds from selling activity: $302,422 (CEO: $282,366, President: $157,257).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access